

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.81518955 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 9.10601603 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.94166236 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.95614872 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 6.95614872 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.67896705 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 6.67896705 |
| 8 | drug metabolic process (GO:0017144) | 6.26819855 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.26427274 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 6.17661305 |
| 11 | oxidative demethylation (GO:0070989) | 6.04925877 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.82155118 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 5.58239852 |
| 14 | regulation of protein activation cascade (GO:2000257) | 5.57791122 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.53848909 |
| 16 | tryptophan catabolic process (GO:0006569) | 5.51932931 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 5.51932931 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 5.51932931 |
| 19 | urea cycle (GO:0000050) | 5.49645974 |
| 20 | urea metabolic process (GO:0019627) | 5.49645974 |
| 21 | glucuronate metabolic process (GO:0019585) | 5.48506579 |
| 22 | uronic acid metabolic process (GO:0006063) | 5.48506579 |
| 23 | ethanol metabolic process (GO:0006067) | 5.43941527 |
| 24 | kynurenine metabolic process (GO:0070189) | 5.38571113 |
| 25 | bile acid biosynthetic process (GO:0006699) | 5.38543279 |
| 26 | glyoxylate metabolic process (GO:0046487) | 5.32434528 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.31691144 |
| 28 | protein carboxylation (GO:0018214) | 5.31691144 |
| 29 | regulation of plasminogen activation (GO:0010755) | 5.30986109 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 5.30416923 |
| 31 | regulation of fibrinolysis (GO:0051917) | 5.28261160 |
| 32 | regulation of complement activation (GO:0030449) | 5.22337804 |
| 33 | regulation of humoral immune response (GO:0002920) | 5.18961580 |
| 34 | sulfur amino acid catabolic process (GO:0000098) | 5.17644220 |
| 35 | tryptophan metabolic process (GO:0006568) | 5.16851893 |
| 36 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.13327463 |
| 37 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 5.11538599 |
| 38 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 5.11538599 |
| 39 | regulation of triglyceride catabolic process (GO:0010896) | 5.06818791 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 5.04926852 |
| 41 | cysteine metabolic process (GO:0006534) | 4.93906282 |
| 42 | phenylpropanoid metabolic process (GO:0009698) | 4.87573062 |
| 43 | S-adenosylmethionine metabolic process (GO:0046500) | 4.86357843 |
| 44 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.85495830 |
| 45 | negative regulation of blood coagulation (GO:0030195) | 4.74128851 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.74128851 |
| 47 | reverse cholesterol transport (GO:0043691) | 4.73796465 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.72444673 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.72444673 |
| 50 | plasma lipoprotein particle remodeling (GO:0034369) | 4.72444673 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 4.72251515 |
| 52 | bile acid metabolic process (GO:0008206) | 4.68231058 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 4.68101138 |
| 54 | acylglycerol homeostasis (GO:0055090) | 4.65384577 |
| 55 | triglyceride homeostasis (GO:0070328) | 4.65384577 |
| 56 | serine family amino acid catabolic process (GO:0009071) | 4.61599444 |
| 57 | phospholipid efflux (GO:0033700) | 4.54623962 |
| 58 | tyrosine metabolic process (GO:0006570) | 4.44516962 |
| 59 | aromatic amino acid family metabolic process (GO:0009072) | 4.44348595 |
| 60 | homocysteine metabolic process (GO:0050667) | 4.42593925 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 4.32971859 |
| 62 | negative regulation of coagulation (GO:0050819) | 4.30582728 |
| 63 | negative regulation of wound healing (GO:0061045) | 4.29129145 |
| 64 | alpha-amino acid catabolic process (GO:1901606) | 4.21834663 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 4.21436982 |
| 66 | negative regulation of sterol transport (GO:0032372) | 4.21436982 |
| 67 | lysine metabolic process (GO:0006553) | 4.20069574 |
| 68 | lysine catabolic process (GO:0006554) | 4.20069574 |
| 69 | cholesterol efflux (GO:0033344) | 4.10888523 |
| 70 | alkaloid metabolic process (GO:0009820) | 4.10221901 |
| 71 | positive regulation of blood coagulation (GO:0030194) | 4.09855015 |
| 72 | positive regulation of hemostasis (GO:1900048) | 4.09855015 |
| 73 | fibrinolysis (GO:0042730) | 4.05258775 |
| 74 | positive regulation of lipid catabolic process (GO:0050996) | 3.99651549 |
| 75 | coenzyme catabolic process (GO:0009109) | 3.97283416 |
| 76 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.93489268 |
| 77 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.93489268 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 3.92576466 |
| 79 | complement activation (GO:0006956) | 3.91703787 |
| 80 | bile acid and bile salt transport (GO:0015721) | 3.91301607 |
| 81 | plasma lipoprotein particle assembly (GO:0034377) | 3.91258631 |
| 82 | * acute-phase response (GO:0006953) | 3.91148211 |
| 83 | negative regulation of complement activation (GO:0045916) | 3.90697839 |
| 84 | negative regulation of lipase activity (GO:0060192) | 3.90283073 |
| 85 | imidazole-containing compound metabolic process (GO:0052803) | 3.89665512 |
| 86 | cellular amino acid catabolic process (GO:0009063) | 3.89310036 |
| 87 | complement activation, classical pathway (GO:0006958) | 3.88253724 |
| 88 | ethanol oxidation (GO:0006069) | 3.85536710 |
| 89 | opsonization (GO:0008228) | 3.84995836 |
| 90 | indolalkylamine metabolic process (GO:0006586) | 3.84217643 |
| 91 | hormone catabolic process (GO:0042447) | 3.84028620 |
| 92 | protein activation cascade (GO:0072376) | 3.81821083 |
| 93 | flavonoid metabolic process (GO:0009812) | 3.81314234 |
| 94 | glycine metabolic process (GO:0006544) | 3.79939539 |
| 95 | response to mercury ion (GO:0046689) | 3.78596711 |
| 96 | positive regulation of coagulation (GO:0050820) | 3.76767177 |
| 97 | benzene-containing compound metabolic process (GO:0042537) | 3.76504202 |
| 98 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.76086234 |
| 99 | amine catabolic process (GO:0009310) | 3.75610085 |
| 100 | cellular biogenic amine catabolic process (GO:0042402) | 3.75610085 |
| 101 | glutamate metabolic process (GO:0006536) | 3.73476021 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.73232973 |
| 103 | arginine metabolic process (GO:0006525) | 3.73185459 |
| 104 | cytolysis (GO:0019835) | 3.72189511 |
| 105 | low-density lipoprotein particle remodeling (GO:0034374) | 3.71512100 |
| 106 | intestinal cholesterol absorption (GO:0030299) | 3.70777320 |
| 107 | regulation of apoptotic cell clearance (GO:2000425) | 3.68323638 |
| 108 | heme transport (GO:0015886) | 3.67897873 |
| 109 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67891218 |
| 110 | serine family amino acid metabolic process (GO:0009069) | 3.67737239 |
| 111 | cellular glucuronidation (GO:0052695) | 3.67594205 |
| 112 | aldehyde catabolic process (GO:0046185) | 3.65211520 |
| 113 | cellular modified amino acid catabolic process (GO:0042219) | 3.64971576 |
| 114 | plasma lipoprotein particle organization (GO:0071827) | 3.64909371 |
| 115 | cholesterol homeostasis (GO:0042632) | 3.64123442 |
| 116 | regulation of acute inflammatory response (GO:0002673) | 3.61537183 |
| 117 | negative regulation of protein activation cascade (GO:2000258) | 3.61457843 |
| 118 | * acute inflammatory response (GO:0002526) | 3.59214098 |
| 119 | sterol homeostasis (GO:0055092) | 3.58609883 |
| 120 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.56491281 |
| 121 | regulation of cholesterol homeostasis (GO:2000188) | 3.53327825 |
| 122 | acetyl-CoA metabolic process (GO:0006084) | 3.53098627 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.52861112 |
| 124 | fatty acid beta-oxidation (GO:0006635) | 3.52425235 |
| 125 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52153088 |
| 126 | fatty acid oxidation (GO:0019395) | 3.51899336 |
| 127 | carboxylic acid catabolic process (GO:0046395) | 3.51877564 |
| 128 | organic acid catabolic process (GO:0016054) | 3.51877564 |
| 129 | cofactor catabolic process (GO:0051187) | 3.49059546 |
| 130 | drug catabolic process (GO:0042737) | 3.45999788 |
| 131 | lipid oxidation (GO:0034440) | 3.45508686 |
| 132 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.45205490 |
| 133 | xenobiotic metabolic process (GO:0006805) | 3.44387916 |
| 134 | serine family amino acid biosynthetic process (GO:0009070) | 3.39781907 |
| 135 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.38257125 |
| 136 | sodium-independent organic anion transport (GO:0043252) | 3.37309815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.79758893 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.74588004 |
| 3 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.35776773 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.31394808 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.10914218 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.95004722 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.89829597 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86415318 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.74639389 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.63383104 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.36887430 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.17605955 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2224955 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95244231 |
| 15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.83399515 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.79746147 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.68829969 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58401618 |
| 19 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.55056945 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.42229157 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.34824552 |
| 22 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.30994883 |
| 23 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.26512697 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.23187315 |
| 25 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18592097 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16661916 |
| 27 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15857806 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13207500 |
| 29 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11594783 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11367654 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10186764 |
| 32 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10047821 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04643296 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98522668 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98352249 |
| 36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96785589 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95325208 |
| 38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.94524217 |
| 39 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93771371 |
| 40 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86511915 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86345058 |
| 42 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84831776 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.84309226 |
| 44 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.84198000 |
| 45 | CBP_21632823_ChIP-Seq_H3396_Human | 0.82344951 |
| 46 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.80149237 |
| 47 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.79504524 |
| 48 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78318725 |
| 49 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.76576819 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76369799 |
| 51 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.74858518 |
| 52 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73333372 |
| 53 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.73290841 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71184720 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.71102075 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.71046564 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.71046564 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.69707456 |
| 59 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69659324 |
| 60 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.69475035 |
| 61 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.68783429 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68178652 |
| 63 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.67987031 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.67123533 |
| 65 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65794519 |
| 66 | NFYA_21822215_ChIP-Seq_K562_Human | 0.65557867 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.65221841 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.65056824 |
| 69 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65015412 |
| 70 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.64414084 |
| 71 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63638363 |
| 72 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.63461447 |
| 73 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62760303 |
| 74 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.62291425 |
| 75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62174961 |
| 76 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.62171090 |
| 77 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.61814817 |
| 78 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61015254 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 0.60880270 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.60149646 |
| 81 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.59973931 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.59810197 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.59321121 |
| 84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.59116962 |
| 85 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.57646766 |
| 86 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.56795870 |
| 87 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.56695172 |
| 88 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56678609 |
| 89 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56633309 |
| 90 | GATA2_19941826_ChIP-Seq_K562_Human | 0.55998193 |
| 91 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.55922462 |
| 92 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55458269 |
| 93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55064359 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.55020398 |
| 95 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.54662973 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.54164341 |
| 97 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.53942042 |
| 98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.53360710 |
| 99 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52470049 |
| 100 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.52307128 |
| 101 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52228837 |
| 102 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51469715 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51445149 |
| 104 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.51085535 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.50542138 |
| 106 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.50076366 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49823057 |
| 108 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.49613561 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.49367823 |
| 110 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.49319343 |
| 111 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.49304155 |
| 112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.49145467 |
| 113 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.48803203 |
| 114 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.48643550 |
| 115 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.48551491 |
| 116 | AR_20517297_ChIP-Seq_VCAP_Human | 0.48517862 |
| 117 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.47654958 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.47506800 |
| 119 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.47447103 |
| 120 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.46934570 |
| 121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.46495144 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.46488936 |
| 123 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.46269630 |
| 124 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.46196256 |
| 125 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.46069551 |
| 126 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.45918754 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45777100 |
| 128 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.45312569 |
| 129 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.45136269 |
| 130 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.45020285 |
| 131 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.45007163 |
| 132 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.44433112 |
| 133 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.43566165 |
| 134 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.43545618 |
| 135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.43301700 |
| 136 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43139121 |
| 137 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.42716613 |
| 138 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.42493044 |
| 139 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.42398514 |
| 140 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.42398514 |
| 141 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.42311044 |
| 142 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.42107452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.70309392 |
| 2 | MP0005360_urolithiasis | 6.90646871 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.80677610 |
| 4 | MP0005365_abnormal_bile_salt | 5.78095067 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.67692201 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.81173136 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.70666590 |
| 8 | MP0003252_abnormal_bile_duct | 3.45562683 |
| 9 | MP0009840_abnormal_foam_cell | 3.36073820 |
| 10 | MP0005083_abnormal_biliary_tract | 2.90263377 |
| 11 | MP0005332_abnormal_amino_acid | 2.58883281 |
| 12 | MP0003195_calcinosis | 2.48268999 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.34880385 |
| 14 | MP0002118_abnormal_lipid_homeostasis | 2.25012724 |
| 15 | * MP0003191_abnormal_cellular_cholesterol | 2.23914633 |
| 16 | MP0000609_abnormal_liver_physiology | 2.23173527 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.93926271 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.92026067 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.82197092 |
| 20 | MP0005670_abnormal_white_adipose | 1.73422610 |
| 21 | MP0001764_abnormal_homeostasis | 1.65982255 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 1.63421720 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56457650 |
| 24 | MP0003868_abnormal_feces_composition | 1.53370943 |
| 25 | MP0003186_abnormal_redox_activity | 1.47730011 |
| 26 | MP0003011_delayed_dark_adaptation | 1.44274252 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.28937241 |
| 28 | MP0004130_abnormal_muscle_cell | 1.28377169 |
| 29 | MP0000604_amyloidosis | 1.25751752 |
| 30 | MP0003656_abnormal_erythrocyte_physiolo | 1.23594779 |
| 31 | MP0000598_abnormal_liver_morphology | 1.18762861 |
| 32 | MP0005451_abnormal_body_composition | 1.18525382 |
| 33 | MP0010368_abnormal_lymphatic_system | 1.17614944 |
| 34 | MP0009697_abnormal_copulation | 1.16113732 |
| 35 | MP0002254_reproductive_system_inflammat | 1.15386511 |
| 36 | MP0003724_increased_susceptibility_to | 1.12686404 |
| 37 | MP0002971_abnormal_brown_adipose | 1.11248147 |
| 38 | * MP0009763_increased_sensitivity_to | 1.10799721 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.09968458 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.07729014 |
| 41 | MP0005647_abnormal_sex_gland | 1.05026081 |
| 42 | * MP0009764_decreased_sensitivity_to | 1.04188238 |
| 43 | MP0008469_abnormal_protein_level | 1.03752627 |
| 44 | MP0003690_abnormal_glial_cell | 1.03137895 |
| 45 | MP0003436_decreased_susceptibility_to | 0.98835800 |
| 46 | MP0005334_abnormal_fat_pad | 0.96738768 |
| 47 | MP0002282_abnormal_trachea_morphology | 0.90067154 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 0.89475805 |
| 49 | * MP0009642_abnormal_blood_homeostasis | 0.87901656 |
| 50 | MP0001915_intracranial_hemorrhage | 0.87173778 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 0.86323656 |
| 52 | MP0001661_extended_life_span | 0.85846949 |
| 53 | MP0008438_abnormal_cutaneous_collagen | 0.85368552 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.81460213 |
| 55 | MP0005376_homeostasis/metabolism_phenot | 0.80952625 |
| 56 | MP0005535_abnormal_body_temperature | 0.80203181 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 0.78602969 |
| 58 | MP0005464_abnormal_platelet_physiology | 0.78149103 |
| 59 | MP0006036_abnormal_mitochondrial_physio | 0.75986224 |
| 60 | MP0009115_abnormal_fat_cell | 0.74622157 |
| 61 | MP0008872_abnormal_physiological_respon | 0.73714330 |
| 62 | MP0004185_abnormal_adipocyte_glucose | 0.73667235 |
| 63 | MP0005187_abnormal_penis_morphology | 0.72006642 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.71687162 |
| 65 | MP0005448_abnormal_energy_balance | 0.70474164 |
| 66 | MP0003075_altered_response_to | 0.69673995 |
| 67 | MP0001756_abnormal_urination | 0.69298924 |
| 68 | MP0005408_hypopigmentation | 0.68977022 |
| 69 | * MP0009765_abnormal_xenobiotic_induced | 0.66466326 |
| 70 | MP0003879_abnormal_hair_cell | 0.65147971 |
| 71 | MP0002796_impaired_skin_barrier | 0.64973159 |
| 72 | MP0003329_amyloid_beta_deposits | 0.63755234 |
| 73 | MP0005375_adipose_tissue_phenotype | 0.62949957 |
| 74 | MP0005164_abnormal_response_to | 0.62313144 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.62204182 |
| 76 | MP0005220_abnormal_exocrine_pancreas | 0.60880377 |
| 77 | MP0009053_abnormal_anal_canal | 0.58748088 |
| 78 | MP0002970_abnormal_white_adipose | 0.58489011 |
| 79 | MP0005058_abnormal_lysosome_morphology | 0.57531616 |
| 80 | MP0005266_abnormal_metabolism | 0.57419045 |
| 81 | MP0000249_abnormal_blood_vessel | 0.56738931 |
| 82 | MP0004883_abnormal_blood_vessel | 0.56562352 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.56329603 |
| 84 | MP0000639_abnormal_adrenal_gland | 0.55397872 |
| 85 | MP0005166_decreased_susceptibility_to | 0.55329985 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.54966805 |
| 87 | MP0002060_abnormal_skin_morphology | 0.54021679 |
| 88 | MP0009785_altered_susceptibility_to | 0.53486209 |
| 89 | MP0005275_abnormal_skin_tensile | 0.51440456 |
| 90 | MP0005395_other_phenotype | 0.50918331 |
| 91 | MP0005023_abnormal_wound_healing | 0.50850358 |
| 92 | MP0003638_abnormal_response/metabolism_ | 0.49473805 |
| 93 | MP0001881_abnormal_mammary_gland | 0.48325549 |
| 94 | MP0002168_other_aberrant_phenotype | 0.48034065 |
| 95 | MP0008873_increased_physiological_sensi | 0.47457766 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.46738726 |
| 97 | MP0001853_heart_inflammation | 0.45549445 |
| 98 | MP0001533_abnormal_skeleton_physiology | 0.45446567 |
| 99 | MP0000579_abnormal_nail_morphology | 0.45202028 |
| 100 | MP0003303_peritoneal_inflammation | 0.44518116 |
| 101 | MP0002132_abnormal_respiratory_system | 0.43307678 |
| 102 | MP0002419_abnormal_innate_immunity | 0.42389436 |
| 103 | MP0008874_decreased_physiological_sensi | 0.42046083 |
| 104 | MP0001243_abnormal_dermal_layer | 0.41792547 |
| 105 | MP0003953_abnormal_hormone_level | 0.40780796 |
| 106 | MP0000467_abnormal_esophagus_morphology | 0.39643606 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.39528019 |
| 108 | MP0000566_synostosis | 0.35725126 |
| 109 | MP0002332_abnormal_exercise_endurance | 0.34514325 |
| 110 | MP0001851_eye_inflammation | 0.32548604 |
| 111 | MP0005397_hematopoietic_system_phenotyp | 0.32244744 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.32244744 |
| 113 | MP0002128_abnormal_blood_circulation | 0.24898657 |
| 114 | MP0000920_abnormal_myelination | 0.19035268 |
| 115 | MP0003633_abnormal_nervous_system | 0.18352915 |
| 116 | MP0003632_abnormal_nervous_system | 0.18188068 |
| 117 | MP0005197_abnormal_uvea_morphology | 0.17530635 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.27660683 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.72411647 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.50499268 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.19028109 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.18305318 |
| 6 | Xanthomatosis (HP:0000991) | 6.16700852 |
| 7 | Complement deficiency (HP:0004431) | 6.12565902 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.76736308 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.75161326 |
| 10 | Joint hemorrhage (HP:0005261) | 4.83390665 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.78530630 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.63317582 |
| 13 | Abnormality of complement system (HP:0005339) | 4.53627297 |
| 14 | Epidermoid cyst (HP:0200040) | 4.47407477 |
| 15 | Hyperammonemia (HP:0001987) | 4.40965851 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.38644684 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.36851255 |
| 18 | Ketosis (HP:0001946) | 4.05393928 |
| 19 | Hyperglycinemia (HP:0002154) | 4.03520376 |
| 20 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.92993428 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.87103025 |
| 22 | Hyperglycinuria (HP:0003108) | 3.86939092 |
| 23 | Abnormality of methionine metabolism (HP:0010901) | 3.85590804 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.82993822 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.76522916 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76522916 |
| 27 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.75864500 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.72531918 |
| 29 | Fat malabsorption (HP:0002630) | 3.69073438 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.60630828 |
| 31 | Spontaneous abortion (HP:0005268) | 3.47645056 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.43660227 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 3.42493106 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.35885363 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35504733 |
| 36 | Myocardial infarction (HP:0001658) | 3.24124324 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17189105 |
| 38 | Conjugated hyperbilirubinemia (HP:0002908) | 3.09311553 |
| 39 | Amyloidosis (HP:0011034) | 3.03853937 |
| 40 | Hyperbilirubinemia (HP:0002904) | 2.96619439 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.91169025 |
| 42 | Skin nodule (HP:0200036) | 2.86959172 |
| 43 | Ketoacidosis (HP:0001993) | 2.86506012 |
| 44 | Glomerulonephritis (HP:0000099) | 2.85183480 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.82357808 |
| 46 | Steatorrhea (HP:0002570) | 2.80273317 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.74498669 |
| 48 | Delayed CNS myelination (HP:0002188) | 2.71410386 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.64923425 |
| 50 | Gingival bleeding (HP:0000225) | 2.63629150 |
| 51 | Osteomalacia (HP:0002749) | 2.61339232 |
| 52 | Metabolic acidosis (HP:0001942) | 2.56785461 |
| 53 | Purpura (HP:0000979) | 2.55502975 |
| 54 | Neonatal hypoglycemia (HP:0001998) | 2.54856652 |
| 55 | Hypochromic microcytic anemia (HP:0004840) | 2.50054737 |
| 56 | Vascular calcification (HP:0004934) | 2.49017424 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.48930512 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.48930512 |
| 59 | Rickets (HP:0002748) | 2.45843774 |
| 60 | Spastic diplegia (HP:0001264) | 2.41627984 |
| 61 | Esophageal varix (HP:0002040) | 2.39606491 |
| 62 | Mitral stenosis (HP:0001718) | 2.39373970 |
| 63 | Lethargy (HP:0001254) | 2.37057434 |
| 64 | Fair hair (HP:0002286) | 2.36502037 |
| 65 | Hypertriglyceridemia (HP:0002155) | 2.36175700 |
| 66 | Thrombophlebitis (HP:0004418) | 2.33401761 |
| 67 | Hemorrhage of the eye (HP:0011885) | 2.32976695 |
| 68 | Hypoglycemic seizures (HP:0002173) | 2.31624291 |
| 69 | Gout (HP:0001997) | 2.30544334 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.26969747 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.26646257 |
| 72 | Pancreatitis (HP:0001733) | 2.24952280 |
| 73 | Cholelithiasis (HP:0001081) | 2.24457369 |
| 74 | Joint swelling (HP:0001386) | 2.21362367 |
| 75 | Cholecystitis (HP:0001082) | 2.20064863 |
| 76 | Abnormal gallbladder physiology (HP:0012438) | 2.20064863 |
| 77 | Menorrhagia (HP:0000132) | 2.19895961 |
| 78 | Neonatal onset (HP:0003623) | 2.19759984 |
| 79 | Nephritis (HP:0000123) | 2.18148208 |
| 80 | Acanthocytosis (HP:0001927) | 2.15397894 |
| 81 | Abnormality of iron homeostasis (HP:0011031) | 2.14348604 |
| 82 | Irritability (HP:0000737) | 2.13218035 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.10744404 |
| 84 | Late onset (HP:0003584) | 2.09824053 |
| 85 | Cerebral edema (HP:0002181) | 2.08562518 |
| 86 | Abnormal cartilage morphology (HP:0002763) | 2.06777977 |
| 87 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05112267 |
| 88 | Vomiting (HP:0002013) | 2.01099536 |
| 89 | Brushfield spots (HP:0001088) | 1.99167905 |
| 90 | Hydroxyprolinuria (HP:0003080) | 1.96405206 |
| 91 | Abnormality of proline metabolism (HP:0010907) | 1.96405206 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 1.95868170 |
| 93 | Malnutrition (HP:0004395) | 1.95641810 |
| 94 | Elevated alkaline phosphatase (HP:0003155) | 1.95124794 |
| 95 | Generalized aminoaciduria (HP:0002909) | 1.90628632 |
| 96 | Hyperphosphaturia (HP:0003109) | 1.87687379 |
| 97 | Abnormality of the gallbladder (HP:0005264) | 1.86416666 |
| 98 | Enlarged kidneys (HP:0000105) | 1.85991838 |
| 99 | Opisthotonus (HP:0002179) | 1.85599888 |
| 100 | Pulmonary embolism (HP:0002204) | 1.83271247 |
| 101 | Abnormal delivery (HP:0001787) | 1.82932970 |
| 102 | Arthropathy (HP:0003040) | 1.80187749 |
| 103 | Polycythemia (HP:0001901) | 1.80038980 |
| 104 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79567880 |
| 105 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78737890 |
| 106 | Elevated hepatic transaminases (HP:0002910) | 1.78158441 |
| 107 | Abnormality of vitamin metabolism (HP:0100508) | 1.77596296 |
| 108 | Gangrene (HP:0100758) | 1.77225341 |
| 109 | Nausea (HP:0002018) | 1.76712503 |
| 110 | Increased serum ferritin (HP:0003281) | 1.75549719 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.71155042 |
| 112 | Increased mean platelet volume (HP:0011877) | 1.71134534 |
| 113 | Glycosuria (HP:0003076) | 1.70569852 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 1.70569852 |
| 115 | Poikilocytosis (HP:0004447) | 1.68394788 |
| 116 | Cerebral palsy (HP:0100021) | 1.68361107 |
| 117 | Hyperglycemia (HP:0003074) | 1.66224299 |
| 118 | Abnormality of the Achilles tendon (HP:0005109) | 1.65190461 |
| 119 | Epistaxis (HP:0000421) | 1.65007543 |
| 120 | Generalized hypopigmentation of hair (HP:0011358) | 1.64029799 |
| 121 | Hypophosphatemic rickets (HP:0004912) | 1.61785917 |
| 122 | Bifid scrotum (HP:0000048) | 1.59627950 |
| 123 | Increased serum pyruvate (HP:0003542) | 1.58196475 |
| 124 | Abnormal platelet volume (HP:0011876) | 1.55398625 |
| 125 | Abnormal platelet function (HP:0011869) | 1.51199172 |
| 126 | Impaired platelet aggregation (HP:0003540) | 1.51199172 |
| 127 | Atrioventricular block (HP:0001678) | 1.51155124 |
| 128 | Abnormal urine phosphate concentration (HP:0012599) | 1.49512359 |
| 129 | Abnormal biliary tract physiology (HP:0012439) | 1.46911338 |
| 130 | Bile duct proliferation (HP:0001408) | 1.46911338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.18282310 |
| 2 | ERN1 | 5.45446799 |
| 3 | FGFR4 | 4.22268730 |
| 4 | SIK1 | 4.00823340 |
| 5 | TRIB3 | 3.31235770 |
| 6 | TAOK3 | 2.47696053 |
| 7 | PIK3CA | 2.44866454 |
| 8 | INSRR | 2.28510273 |
| 9 | MST1R | 2.21134466 |
| 10 | ERBB4 | 2.18618152 |
| 11 | PKN2 | 1.93112234 |
| 12 | PRPF4B | 1.89440653 |
| 13 | MAP2K4 | 1.79400353 |
| 14 | EPHB1 | 1.76901819 |
| 15 | TYK2 | 1.76418154 |
| 16 | NTRK3 | 1.66433482 |
| 17 | MAPK11 | 1.61966763 |
| 18 | MAP2K3 | 1.59803995 |
| 19 | PTK6 | 1.59714610 |
| 20 | CAMK1D | 1.58299677 |
| 21 | NEK9 | 1.54731024 |
| 22 | DAPK2 | 1.54649719 |
| 23 | NLK | 1.51690185 |
| 24 | PIK3CG | 1.50141384 |
| 25 | TIE1 | 1.45846782 |
| 26 | RIPK1 | 1.43800075 |
| 27 | FGFR2 | 1.42580594 |
| 28 | FLT3 | 1.42462323 |
| 29 | TGFBR2 | 1.40942835 |
| 30 | KDR | 1.36020334 |
| 31 | LATS1 | 1.35180803 |
| 32 | ABL2 | 1.32924592 |
| 33 | JAK2 | 1.31349563 |
| 34 | FRK | 1.27687898 |
| 35 | JAK1 | 1.24224312 |
| 36 | EPHA3 | 1.24141556 |
| 37 | TNK2 | 1.23719825 |
| 38 | PRKCG | 1.17851694 |
| 39 | TBK1 | 1.16318114 |
| 40 | PRKAA2 | 1.15863108 |
| 41 | MAP3K3 | 1.15654705 |
| 42 | CSK | 1.08111680 |
| 43 | FGFR3 | 1.05749032 |
| 44 | PDK2 | 1.04514945 |
| 45 | GRK6 | 1.03807337 |
| 46 | MAP3K2 | 1.02964437 |
| 47 | CAMKK2 | 1.02898796 |
| 48 | CDK6 | 0.95261486 |
| 49 | PRKG1 | 0.94803812 |
| 50 | MET | 0.90221589 |
| 51 | MAPK4 | 0.89141555 |
| 52 | CAMK1G | 0.89093304 |
| 53 | IRAK3 | 0.88731023 |
| 54 | MAP3K11 | 0.85086064 |
| 55 | MAP3K7 | 0.84710712 |
| 56 | MAP3K14 | 0.83443950 |
| 57 | ERBB2 | 0.79247635 |
| 58 | PRKACA | 0.76708371 |
| 59 | EPHA4 | 0.74702124 |
| 60 | GSK3A | 0.71335681 |
| 61 | PRKACG | 0.70030188 |
| 62 | AKT3 | 0.68246710 |
| 63 | PRKCZ | 0.67823416 |
| 64 | PTK2 | 0.67385582 |
| 65 | MAP3K6 | 0.66798348 |
| 66 | MAPK12 | 0.66193386 |
| 67 | PINK1 | 0.65686313 |
| 68 | IKBKE | 0.65130611 |
| 69 | PDPK1 | 0.65069780 |
| 70 | KSR2 | 0.64836544 |
| 71 | PDGFRA | 0.61701108 |
| 72 | CSF1R | 0.61430659 |
| 73 | MAP2K1 | 0.57592350 |
| 74 | CSNK1E | 0.57103628 |
| 75 | ZAP70 | 0.56210024 |
| 76 | PRKACB | 0.54841991 |
| 77 | MAP2K6 | 0.53693300 |
| 78 | MAP3K13 | 0.53603205 |
| 79 | MAP3K10 | 0.53585894 |
| 80 | TAOK2 | 0.53428023 |
| 81 | PRKCB | 0.53112190 |
| 82 | EPHB2 | 0.51384466 |
| 83 | PRKAA1 | 0.51059202 |
| 84 | SGK3 | 0.50864236 |
| 85 | RPS6KA3 | 0.50842940 |
| 86 | CSNK1D | 0.50806729 |
| 87 | CAMKK1 | 0.50036380 |
| 88 | IGF1R | 0.49874677 |
| 89 | GRK1 | 0.48548678 |
| 90 | SGK494 | 0.47001232 |
| 91 | SGK223 | 0.47001232 |
| 92 | SCYL2 | 0.46597485 |
| 93 | SRC | 0.46457428 |
| 94 | BLK | 0.46434042 |
| 95 | RET | 0.46264653 |
| 96 | PRKCA | 0.46122991 |
| 97 | SGK1 | 0.45003719 |
| 98 | KIT | 0.44905548 |
| 99 | CAMK2G | 0.44658241 |
| 100 | BRSK2 | 0.42905099 |
| 101 | PDK4 | 0.41370543 |
| 102 | PDK3 | 0.41370543 |
| 103 | EGFR | 0.41168851 |
| 104 | BMX | 0.40768176 |
| 105 | CDK4 | 0.39555727 |
| 106 | MAP3K1 | 0.39224606 |
| 107 | DYRK1B | 0.37974187 |
| 108 | FER | 0.37862034 |
| 109 | MAP4K1 | 0.37265123 |
| 110 | CSNK2A1 | 0.37138164 |
| 111 | EPHA2 | 0.36324877 |
| 112 | PDK1 | 0.36314775 |
| 113 | LRRK2 | 0.35064588 |
| 114 | MYLK | 0.34867562 |
| 115 | JAK3 | 0.33513939 |
| 116 | IRAK1 | 0.33149985 |
| 117 | MAPK15 | 0.33045214 |
| 118 | MTOR | 0.32479899 |
| 119 | PRKCH | 0.30763542 |
| 120 | CSNK2A2 | 0.30753424 |
| 121 | ABL1 | 0.30479989 |
| 122 | MAPKAPK3 | 0.30300021 |
| 123 | MAPK3 | 0.30087005 |
| 124 | STK38L | 0.29122120 |
| 125 | PRKCQ | 0.28704002 |
| 126 | MAP3K5 | 0.28530996 |
| 127 | ITK | 0.27129407 |
| 128 | BTK | 0.26021365 |
| 129 | MAPK7 | 0.25920489 |
| 130 | CAMK4 | 0.24334041 |
| 131 | LATS2 | 0.23111284 |
| 132 | PKN1 | 0.21477695 |
| 133 | SGK2 | 0.20239089 |
| 134 | ICK | 0.20026548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38568081 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.58201722 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.20633201 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10203374 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.07139126 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.06660621 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60331198 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57723236 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55948762 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.55233038 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46188296 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45340387 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.23081117 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.21576466 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.11574790 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.11257232 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06487019 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.04926577 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.98851351 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94382986 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89515338 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88127894 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87334372 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.84474992 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77578323 |
| 26 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.69765102 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.65868042 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60413750 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.60265282 |
| 30 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60210246 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56402474 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.54094997 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47407084 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46990262 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.39638342 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39532299 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37720839 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36987837 |
| 39 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.31235890 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27605905 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.25791621 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.24385408 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23103238 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.20690807 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18558873 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17709428 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.10584380 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01989308 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97719173 |
| 50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94104957 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93809678 |
| 52 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91912494 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90558100 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87780728 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86569109 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82841469 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.82243937 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81359358 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.81333326 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.81079259 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.73989417 |
| 62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72499729 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71681084 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70116317 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59701219 |
| 66 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53005285 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52146637 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46956059 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.44628294 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40560665 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.38152175 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29491168 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27046229 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23970302 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21303502 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19263866 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17445374 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13032340 |
| 79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04984152 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.01081509 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.00104592 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2727521 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2576790 |
| 84 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2368585 |
| 85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2332376 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2277017 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2174692 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1610044 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1609511 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1557036 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | -0.1548313 |
| 92 | Malaria_Homo sapiens_hsa05144 | -0.1513605 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1495570 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1403453 |
| 95 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1076073 |
| 96 | Lysosome_Homo sapiens_hsa04142 | -0.1012803 |
| 97 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1000665 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0958338 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0941183 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.0823813 |
| 101 | Hepatitis C_Homo sapiens_hsa05160 | -0.0818044 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0815543 |
| 103 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0696196 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0684954 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | -0.0386917 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0329067 |
| 107 | Pertussis_Homo sapiens_hsa05133 | -0.0210002 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0192013 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0173405 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0011781 |

